Correlation Between NYSE Composite and Ovid Therapeutics
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Ovid Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Ovid Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Ovid Therapeutics, you can compare the effects of market volatilities on NYSE Composite and Ovid Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Ovid Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Ovid Therapeutics.
Diversification Opportunities for NYSE Composite and Ovid Therapeutics
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between NYSE and Ovid is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Ovid Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ovid Therapeutics and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Ovid Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ovid Therapeutics has no effect on the direction of NYSE Composite i.e., NYSE Composite and Ovid Therapeutics go up and down completely randomly.
Pair Corralation between NYSE Composite and Ovid Therapeutics
Assuming the 90 days trading horizon NYSE Composite is expected to generate 1.74 times less return on investment than Ovid Therapeutics. But when comparing it to its historical volatility, NYSE Composite is 6.89 times less risky than Ovid Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Ovid Therapeutics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 179.00 in Ovid Therapeutics on August 25, 2024 and sell it today you would lose (74.00) from holding Ovid Therapeutics or give up 41.34% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
NYSE Composite vs. Ovid Therapeutics
Performance |
| Timeline |
NYSE Composite and Ovid Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Ovid Therapeutics
Pair trading matchups for Ovid Therapeutics
Pair Trading with NYSE Composite and Ovid Therapeutics
The main advantage of trading using opposite NYSE Composite and Ovid Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Ovid Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ovid Therapeutics will offset losses from the drop in Ovid Therapeutics' long position.| NYSE Composite vs. Glacier Bancorp | NYSE Composite vs. LithiumBank Resources Corp | NYSE Composite vs. Stepstone Group | NYSE Composite vs. Pintec Technology Holdings |
| Ovid Therapeutics vs. CytomX Therapeutics | Ovid Therapeutics vs. Spero Therapeutics | Ovid Therapeutics vs. Instil Bio | Ovid Therapeutics vs. NextCure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |